SAN DIEGO, March 25, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer.

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume ...

Australia, China, Chile, and Argentina — account for 90% of the production of Lithium. Sodium and potassium batteries are ...

DexCom (DXCM) announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibility for ...

SAN DIEGO, March 25, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this ...

Dexcom (Nasdaq:DXCM) has a new chief commercial officer with significant experience at another major medtech company.

The appointment of Jon Coleman as chief commercial officer is based on a press release statement from DexCom, Inc. In other recent news, DexCom reported fourth-quarter earnings with adjusted ...

SAN DIEGO - DexCom, Inc. (NASDAQ: DXCM), a prominent player in glucose biosensing technology with a market capitalization of $28.75 billion and an "GREAT" financial health rating according to ...

This innovation, along with the appointment of Jon Coleman as the Chief Commercial Officer, potentially bolstered investor confidence. Meanwhile, broader market trends showed a slight decline in ...

At UFC London, Tom Aspinall trolled Jon Jones once again by showing a rubber duck when the cameras cut to him on the ...

“We are grateful for the continued support from local officials and the community,” said Jon Coleman, senior vice president of strategy and business development at Denver Air Connection.